Investors in GERN have chance to lead class action suit against Geron Corporation

Investors who have holdings in Geron Corporation (NASDAQ: GERN) may be eligible to be a part of a class-action lawsuit against the company. Bronstein, Gewirtz, and Grossman, LLC are offering legal representation for investors who wish to participate in the lawsuit. This presents an opportunity for investors to potentially recover losses incurred due to alleged violations of federal securities laws by Geron Corporation.

The class action lawsuit alleges that Geron Corporation made false and misleading statements regarding the results of a clinical drug trial for imetelstat, their telomerase inhibitor. The lawsuit claims that the company misrepresented the safety and efficacy of imetelstat, causing the stock price to artificially inflate. However, when the truth regarding the drug trial results was revealed, the stock price plummeted, resulting in significant losses for investors.

Investors who purchased shares of Geron Corporation between March 19, 2018, and September 26, 2018, are encouraged to contact Bronstein, Gewirtz, and Grossman, LLC to learn more about their rights and options in this class action lawsuit. By participating in the lawsuit, investors may have the opportunity to recover financial losses incurred as a result of Geron Corporation’s alleged securities law violations.

The legal team at Bronstein, Gewirtz, and Grossman, LLC have a proven track record of representing investors in similar securities fraud cases and are dedicated to seeking justice on behalf of their clients. Investors who believe they have been harmed by Geron Corporation’s actions are urged to take action and contact the law firm to explore their legal options in the class action lawsuit.

It is important for investors to be aware of their rights and options when they believe they have suffered financial losses due to the actions of a company like Geron Corporation. By participating in a class action lawsuit, investors can join together with others who have been similarly affected to hold the company accountable for its alleged securities law violations.

Overall, investors who have holdings in Geron Corporation may have the opportunity to lead a class action lawsuit against the company with the assistance of legal representation from Bronstein, Gewirtz, and Grossman, LLC. By taking action and exploring their legal options, investors may be able to seek justice and potentially recover financial losses incurred as a result of alleged violations of federal securities laws by Geron Corporation.